title: Liposome-encapsulated hemoglobin accelerates skin wound healing in mice.
abstract: Effects of liposome-encapsulated hemoglobin with high O₂ affinity (m-LEH, P₅₀O₂ = 17 mm Hg) on skin wound healing in mice were examined. Two full-thickness dorsal wounds 6 mm in diameter encompassed by silicone stents were created in Balb/c mice. Two days later (day 2), the animals randomly received intravenous m-LEH (2 mL/kg, n = 12), homologous blood transfusion (red blood cell [RBC], n = 11), or saline (n = 12). The same treatment was repeated 4 days after wounding (day 4), and the sizes of the skin defects and ulcers were monitored on days 0, 2, 4, and 7, when all animals were euthanized for morphological studies. While the size of the skin defect in relation to the stent ring remained the same in all groups, the size of the ulcer compared with the skin defect (or silicone stent) became significantly reduced on days 4 and 7 in mice treated with m-LEH (46 ± 10% of pretreatment size, P < 0.01) compared with mice treated with RBC transfusion (73 ± 6%) or saline (76 ± 7%). m-LEH treatment significantly accelerated granulation, increased epithelial thickness, suppressed early granulocyte infiltration, and increased Ki67 expression in accordance with the ulcer size reduction, while there was no difference in surface blood flow or CD31 expression among the groups. The results suggest that m-LEH (2 mL/kg) may accelerate skin wound healing in Balb/c mice via mechanism(s) involving reduced inflammation and increased metabolism, but not by improved hemodynamics or endothelial regeneration.
authors.affiliation: Departments of Plastic Surgery             Cell Transplantation and Regenerative Medicine             Pathology, Tokai University School of Medicine, Kanagawa, Japan.
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Fukui
authors.forename: Akira T
authors.initials: AT
authors.lastname: Kawaguchi
authors.forename: Susumu
authors.initials: S
authors.lastname: Takekoshi
authors.forename: Muneo
authors.initials: M
authors.lastname: Miyasaka
authors.forename: Rica
authors.initials: R
authors.lastname: Tanaka
mesh_terms: D000818:Animals; D001802:Blood Substitutes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000276:immunology; D019394:Ki-67 Antigen / Q000276:immunology; D008081:Liposomes; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000276:immunology; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000293:injuries* / Q000473:pathology; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D001802:Blood Substitutes; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D019394:Ki-67 Antigen; D008081:Liposomes; D019408:Platelet Endothelial Cell Adhesion Molecule-1